Hjem › Parkinsons sykdom › Connecticut › New Haven
Kliniske studier for Parkinsons sykdom i New Haven, CT
14 studier for Parkinsons sykdom søker deltakere på steder i og rundt New Haven (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- XingImaging LLC, New Haven
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
RekruttererFase 2
- Yale University, New Haven
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
RekruttererFase 2/3
- Site-028, New Haven
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Institute for Neurodegenerative Disorders, New Haven
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RekruttererObservasjonsstudie
- Yale School of Medicine's Stephen and Denise Adams Center for Parkinson's Disease Research, New Haven
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RekruttererFase 3
- Institute for Neurodegenerative Disorders, New Haven
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Institute for Neurodegenerative Disorders / XingImaging, LLC, New Haven
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Institute For Neurodegenerative Disorders, New Haven
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Intestinal Immunity in Neurologic Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Yale MS Clinic, North Haven · 7 mi unna
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
- Yale New Haven Hospital, New Haven
Imaging Depression in Parkinson's Disease
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Yale University, New Haven
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
RekruttererObservasjonsstudie
- Digestive Disease Associates, Branford · 6 mi unna
Parkinsons sykdom-studier i andre byer
- New York City, NY23 studier
- Boston, MA19 studier
- Cleveland, OH18 studier
- Minneapolis, MN17 studier
- Nashville, TN15 studier
- Philadelphia, PA14 studier
- San Francisco, CA14 studier
- Charleston, SC13 studier
- Farmington Hills, MI13 studier
- Chicago, IL13 studier
- Miami, FL13 studier
- Aurora, CO12 studier
Andre studier i New Haven
- Ikke-småcellet lungekreft41 studier
- Brystkreft38 studier
- Kreft (alle typer)33 studier
- Metastatisk kreft23 studier
- Lungekreft22 studier
- Plateepitelcancer i hode og hals22 studier
- Eggstokkreft21 studier
- Kolorektal kreft20 studier
- Prostatakreft20 studier
- Akut myelogen leukemi17 studier
- Alkoholbrukforstyrrelse (AUD)17 studier
- Opioidoverdose17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.